Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays a 503 Service Unavailable error with the message 'no healthy upstream', along with a Home link and a revision label, indicating the study page is currently inaccessible. This suggests a temporary site issue rather than a change to the study content.
    Difference
    19%
    Check dated 2026-08-08T17:55:37.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the system or documentation. It does not alter the displayed study details or how the page functions.
    Difference
    0.1%
    Check dated 2026-07-25T10:46:08.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.2 to v3.6.3, indicating a minor update to the page template. It does not alter the study details or data presented.
    Difference
    0.1%
    Check dated 2026-07-03T22:46:27.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous v3.6.0 on the page, signaling an updated release of the platform or page template rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-06-26T20:54:15.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    New help and navigation sections were added to the study details page, including How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment heading formatting was adjusted and revision information updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T13:27:46.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from Revision: v3.5.4 to Revision: v3.5.5, indicating a system/template update. This change does not modify the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T08:38:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.